Ken Griffin Establishment Labs Holdings Inc. Call Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$41.46 - $59.86 $1.21 Million - $1.75 Million	-29,300 Reduced 42.28%	40,000 $1.82 Million
Q1 2024 May 15, 2024	SELL	$24.83 - $51.04 $3.64 Million - $7.47 Million	-146,400 Reduced 67.87%	69,300 $3.53 Million
Q4 2023 Feb 14, 2024	BUY	$21.68 - $45.39 $3.37 Million - $7.05 Million	155,400 Added 257.71%	215,700 $5.58 Million
Q3 2023 Nov 14, 2023	BUY	$47.85 - $72.77 $1.46 Million - $2.22 Million	30,500 Added 102.35%	60,300 $2.96 Million
Q2 2023 Aug 14, 2023	SELL	$64.29 - $75.89 $623,613 - $736,133	-9,700 Reduced 24.56%	29,800 $2.04 Million
Q1 2023 May 15, 2023	BUY	$61.44 - $74.47 $608,256 - $737,253	9,900 Added 33.45%	39,500 $2.68 Million
Q4 2022 Feb 14, 2023	BUY	$51.0 - $72.94 $606,900 - $867,986	11,900 Added 67.23%	29,600 $1.94 Million
Q3 2022 Nov 14, 2022	SELL	$50.45 - $67.84 $1.07 Million - $1.44 Million	-21,200 Reduced 54.5%	17,700 $967,000

131

24.1M

135K

107K

Ticker ESTA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,268,500
Market Cap $1.07B
Description
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.